1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,580 | 3,800 | 09:34 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | BRIEF: WuXi XDC's revenue, profit jump in 2024 | 1 | Bamboo Works | ||
| Mi | WUXI XDC Forecasts NP to Grow 2.6x YoY Last Yr | 1 | AASTOCKS | ||
| Mi | WUXI XDC (02268): POSITIVE PROFIT ALERT | 1 | HKEx | ||
| Di | WuXi AppTec's Shares Jump After Selling 7.2% Stake in WuXi XDC for USD312 Million | 4 | Yicai Global | ||
| Mo | WUXI XDC Plummets 6%+; Shareholder STA Pharmaceutical Cuts Stake | 1 | AASTOCKS | ||
| 06.01. | M Stanley Likes HANSOH PHARMA, WUXI XDC, ALI HEALTH in Biopharma, CRO/CDMO, Internet Health | 6 | AASTOCKS | ||
| 21.11.24 | WUXI XDC (02268): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| 21.11.24 | WUXI XDC (02268): (1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND (2) CHANGE IN COMPOSITION OF BOARD COMMITTEES | 2 | HKEx | ||
| WUXI XDC Aktie jetzt für 0€ handeln | |||||
| 25.10.24 | WUXI XDC (02268): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 25, 2024 | 2 | HKEx | ||
| 24.10.24 | Neues Speziallabel für Krebsstudien: Für eine klinische Krebsstudie nutzt WuXi XDC ein spezielles Lichtschutzlabel ... | 2 | packaging journal | ||
| 23.10.24 | WuXi XDC Taps Schreiner MediPharm for ADC Drug Label Solution | 6 | Contract Pharma | ||
| 09.10.24 | WUXI XDC (02268): FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, OCTOBER 25, 2024 | 1 | HKEx | ||
| 09.10.24 | WUXI XDC (02268): NOTICE OF EXTRAORDINARY GENERAL MEETING | 2 | HKEx | ||
| 09.10.24 | WUXI XDC (02268): REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE ANTIBODIES MASTER SERVICES AGREEMENT AND NOTICE OF EXTRAORDINARY ... | 1 | HKEx | ||
| 04.10.24 | WUXI XDC (02268): CLOSURE OF REGISTER OF MEMBERS | - | HKEx | ||
| 30.09.24 | WUXI XDC (02268): GRANT OF RESTRICTED SHARES UNDER THE 2024 SHARE SCHEME | 1 | HKEx | ||
| 30.09.24 | WUXI XDC (02268): FURTHER DELAY IN DESPATCH OF CIRCULAR | 1 | HKEx | ||
| 26.09.24 | WUXI XDC (02268): INTERIM REPORT 2024 | 1 | HKEx | ||
| 16.09.24 | WUXI XDC (02268): DELAY IN DESPATCH OF CIRCULAR | - | HKEx | ||
| 26.08.24 | WUXI XDC (02268): REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS AGREEMENTS | 1 | HKEx |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEMPUS AI | 34,920 | 0,00 % | Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine | ||
| ADMA BIOLOGICS | 16,710 | 0,00 % | ADMA BIOLOGICS, INC. - 8-K, Current Report | ||
| NUVALENT | 77,44 | +6,98 % | Nuvalent, Inc. - 8-K, Current Report | ||
| SUMMIT THERAPEUTICS | 18,200 | 0,00 % | Why Summit Therapeutics Rocketed 584% in 2024 | ||
| RECURSION PHARMACEUTICALS | 6,420 | 0,00 % | CEO von Recursion Pharmaceuticals verkauft Aktien im Wert von 287.200 US-Dollar | ||
| VERA THERAPEUTICS | 33,880 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 69,59 | 0,00 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities | Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by 2028 Study 1 of Essential3 program for ulixacaltamide... ► Artikel lesen | |
| KEROS THERAPEUTICS | 10,410 | 0,00 % | Keros pulls study of Winrevair rival after safety signal | ||
| HARMONY BIOSCIENCES | 36,930 | +1,40 % | Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenues for Q4 and full year 2024 of $201 million... ► Artikel lesen | |
| DYNE THERAPEUTICS | 15,540 | 0,00 % | Dyne Therapeutics Reports Positive Data From ACHIEVE Study Of DYNE-101 In Myotonic Dystrophy Type 1 | WASHINGTON (dpa-AFX) - Dyne Therapeutics, Inc. (DYN) Friday announced encouraging data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1).... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 27,870 | +3,03 % | Analyst Expectations For Avidity Biosciences' Future | ||
| CG ONCOLOGY | 29,610 | 0,00 % | CG Oncology-Direktor Leonard Post verkauft Aktien im Wert von 29.660 US-Dollar | ||
| STRUCTURE THERAPEUTICS | 26,890 | 0,00 % | Structure Therapeutics Inc.: Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer | SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| QUANTUM-SI | 2,345 | 0,00 % | (QSI) - Analyzing Quantum-Si's Short Interest | ||
| HUMACYTE | 4,580 | 0,00 % | Pre-market Movers: My Size, Nvni Group, Psyence Biomedical, Humacyte, PainReform | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET).In the Green My Size, Inc. (MYSZ) is up over 372% at $6.43.
Nvni... ► Artikel lesen |
WUXI XDC CAYMAN INC gehört der Branche Biotechnologie an. Die relative Kursveränderung beträgt aktuell -1,66 % bei einem Aktienkurs von 3,560 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WUXI XDC CAYMAN INC finden Sie auf Wallstreet Online.
